{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:52:32Z","timestamp":1762505552925},"reference-count":36,"publisher":"Elsevier BV","issue":"19","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.medcli.2009.03.043","type":"journal-article","created":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T09:11:24Z","timestamp":1257066684000},"page":"729-735","source":"Crossref","is-referenced-by-count":9,"title":["Tumores en pacientes con infecci\u00f3n por el virus de la inmunodeficiencia humana: estudio de 139 casos"],"prefix":"10.1016","volume":"133","author":[{"given":"Germ\u00e1n","family":"Ram\u00edrez-Olivencia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Eulalia","family":"Valencia-Ortega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz","family":"Martin-Carbonero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Moreno-Celda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Gonz\u00e1lez-Lahoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2009.03.043_bib1","doi-asserted-by":"crossref","first-page":"S132","DOI":"10.1016\/j.jhep.2005.11.027","article-title":"Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management","volume":"44","author":"N\u00fa\u00f1ez","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2009.03.043_bib2","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1086\/503566","article-title":"HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy","volume":"42","author":"Roling","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2009.03.043_bib3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jac\/dkm475","article-title":"Metabolic consequences and therapeutic options in highly active antiretroviral therapy in human immunodeficiency virus-1 infection","volume":"61","author":"Samaras","year":"2008","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medcli.2009.03.043_bib4","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jhep.2007.06.010","article-title":"Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: A US-Canadian multicenter study","volume":"47","author":"Brau","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.medcli.2009.03.043_bib5","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.164.21.2349","article-title":"Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: A cohort study, 1992\u20132001","volume":"164","author":"Giordano","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.medcli.2009.03.043_bib6","first-page":"373","article-title":"Centers for Disease Control (CDC) Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States","volume":"34","year":"1985","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.medcli.2009.03.043_bib7","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.medcli.2009.03.043_bib8","first-page":"1121","article-title":"HIV infection and cancer in the era of highly active antiretroviral therapy (review)","volume":"17","author":"Barbaro","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.medcli.2009.03.043_bib9","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1086\/424883","article-title":"Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989\u20132002","volume":"39","author":"Bedimo","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medcli.2009.03.043_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","article-title":"Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy","volume":"101","author":"Bonnet","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/01.qai.0000179459.31562.16","article-title":"Comparisons of causes of death and mortality rates among HIV-infected persons: Analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) eras","volume":"41","author":"Crum","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.medcli.2009.03.043_bib12","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2009.03.043_bib13","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/j.ejca.2007.01.028","article-title":"Cancer incidence in AIDS patients in Catalonia, Spain","volume":"43","author":"Galceran","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1468-1293.2007.00468.x","article-title":"Incidence and causes of death in HIV-infected persons receiving highly active antiretroviral therapy compared with estimates for the general population of similar age and from the same geographical area","volume":"8","author":"Martinez","year":"2007","journal-title":"HIV Med"},{"key":"10.1016\/j.medcli.2009.03.043_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: Changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.medcli.2009.03.043_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/01.aids.0000196178.73174.24","article-title":"Deaths in the era of HAART: Contribution of late presentation, treatment exposure, resistance and abnormal laboratory markers","volume":"20","author":"Sabin","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.medcli.2009.03.043_bib17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.medcli.2009.03.043_bib18","first-page":"1860","article-title":"Report of the Committee on Hodgkin's Disease Staging Classification","volume":"31","author":"Carbone","year":"1971","journal-title":"Cancer Res"},{"key":"10.1016\/j.medcli.2009.03.043_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1471-0528.1996.tb09764.x","article-title":"Cervical and vulva cancer: Changes in FIGO definitions of staging","volume":"103","author":"Shepherd","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.medcli.2009.03.043_bib20","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/jnci\/dji085","article-title":"Human immunodeficiency virus\/acquired immunodeficiency syndrome and cancer: Past, present and future","volume":"97","author":"Engels","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.medcli.2009.03.043_bib21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2004-11-4278","article-title":"AIDS-related lymphoproliferative disease","volume":"107","author":"Navarro","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.medcli.2009.03.043_bib22","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","article-title":"Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy","volume":"101","author":"Bonnet","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/ijc.10790","article-title":"Reduced incidence if Kaposi's sarcoma and of systemic non-Hodgkin's lymphoma in HIV-infected individuals treated with highly active antiretroviral therapy","volume":"103","author":"Carrieri","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib24","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1470-2045(03)00983-5","article-title":"Epidemiology of non-Hodgkin lymphomas and other haemolymphopoietic neoplasms in people with AIDS","volume":"4","author":"Dal Maso","year":"2003","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.medcli.2009.03.043_bib25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1157\/13116574","article-title":"GESIDA\/PETHEMA guidelines for the diagnosis and treatment of lymphomas in HIV-infected patients","volume":"130","author":"Miralles","year":"2008","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.medcli.2009.03.043_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2407-6-135","article-title":"HIV and pre-neoplastic and neoplastic lesions of the cervix in South Africa: A case-control study","volume":"6","author":"Moodley","year":"2006","journal-title":"BMC Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib27","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/jama.283.8.1031","article-title":"Incidence of cervical squamous intraepithelial lesions in HIV-infected women","volume":"283","author":"Ellerbrock","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.medcli.2009.03.043_bib28","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1097\/00002030-199812000-00007","article-title":"Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy","volume":"12","author":"Heard","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.medcli.2009.03.043_bib29","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/jnci\/91.3.226","article-title":"Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (HIV)-positive and high-risk HIV-negative women","volume":"91","author":"Palefsky","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.medcli.2009.03.043_bib30","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1006\/gyno.2000.5775","article-title":"Human immunodeficiency virus infection and invasive cervical cancer in South Africa","volume":"77","author":"Lomalisa","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.medcli.2009.03.043_bib31","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1006\/gyno.2000.6104","article-title":"Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): A correlation with HIV viral load and CD4+ count","volume":"80","author":"Davis","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.medcli.2009.03.043_bib32","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1097\/00002030-200309050-00015","article-title":"Impact of HIV infection on invasive cervical cancer in Kenyan women","volume":"17","author":"Gichangi","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.medcli.2009.03.043_bib33","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/cncr.23504","article-title":"Cervical cancer in patients infected with the human immunodeficiency virus","volume":"112","author":"Leitao","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2009.03.043_bib34","first-page":"657","article-title":"AIDS malignancies in the era of highly active antiretroviral therapy","volume":"16","author":"Gates","year":"2002","journal-title":"Oncology"},{"key":"10.1016\/j.medcli.2009.03.043_bib35","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.aids.0000238411.75324.59","article-title":"Trends in cancer risk among people with AIDS in the United States 1980\u2013002","volume":"20","author":"Engels","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/j.medcli.2009.03.043_bib36","first-page":"194","article-title":"HCV infection and cancer risk among HIV-infected individuals","volume":"3","author":"Pradier","year":"2003","journal-title":"Infection"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775309012871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775309012871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:48:30Z","timestamp":1558622910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775309012871"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":36,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0025775309012871"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2009.03.043","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}